| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, MD 21201;
Human Anatomy Section, Department of Morphology and Embryology, University of Ferrara, Ferrara, Italy; and
Institute of Normal Morphology, Chieti, Italy
Here we report that synthetic HIV-1 Tat protein, immobilized on a solid substrate, up-regulates the surface expression of the CXC-chemokine receptor 4 (CXCR4), but not of the CC-chemokine receptor 5 in purified populations of primary resting CD4+ T cells. The Tat-mediated increase of CXCR4 occurred in a well-defined range of concentrations (1–10 nM of immobilized Tat) and time period (4–8 h postincubation). Moreover, the increase of CXCR4 was accompanied by an increased entry of the HXB2 T cell line-tropic (X4-tropic), but not of the BaL macrophage-tropic strain of HIV-1. The ability of Tat to up-regulate CXCR4 expression was abrogated by the protein synthesis inhibitor cycloheximide, clearly indicating the requirement of de novo synthesis. As Tat protein is actively released by HIV-1 infected cells, our data indicate a potentially important role for extracellular Tat in rendering bystander CD4+ T cells more susceptible to infection with X4-tropic HIV-1 isolates.
This article has been cited by other articles:
|
|
 |
|
  R. H. Florese, T. Demberg, P. Xiao, L. Kuller, K. Larsen, L. E. Summers, D. Venzon, A. Cafaro, B. Ensoli, and M. Robert-Guroff Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines J. Immunol., March 15, 2009; 182(6): 3718 - 3727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kalantari, O. F. Harandi, P. A. Hankey, and A. J. Henderson HIV-1 Tat Mediates Degradation of RON Receptor Tyrosine Kinase, a Regulator of Inflammation J. Immunol., July 15, 2008; 181(2): 1548 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bugatti, C. Urbinati, C. Ravelli, E. De Clercq, S. Liekens, and M. Rusnati Heparin-Mimicking Sulfonic Acid Polymers as Multitarget Inhibitors of Human Immunodeficiency Virus Type 1 Tat and gp120 Proteins Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2337 - 2345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Caldwell, R. Gadipatti, K. B. Lane, and V. L. Shepherd HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells J. Leukoc. Biol., January 1, 2006; 79(1): 192 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mondal, C. A. Williams, M. Ali, M. Eilers, and K. C. Agrawal The HIV-1 Tat Protein Selectively Enhances CXCR4 and Inhibits CCR5 Expression in Megakaryocytic K562 Cells Experimental Biology and Medicine, October 1, 2005; 230(9): 631 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mascarell, C. Fayolle, C. Bauche, D. Ladant, and C. Leclerc Induction of Neutralizing Antibodies and Th1-Polarized and CD4-Independent CD8+ T-Cell Responses following Delivery of Human Immunodeficiency Virus Type 1 Tat Protein by Recombinant Adenylate Cyclase of Bordetella pertussis J. Virol., August 1, 2005; 79(15): 9872 - 9884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Ruckwardt, I. Tikhonov, S. Berg, G. S. Hatfield, A. Chandra, P. Chandra, B. Gilliam, R. R. Redfield, R. C. Gallo, and C. D. Pauza Sequence Variation within the Dominant Amino Terminus Epitope Affects Antibody Binding and Neutralization of Human Immunodeficiency Virus Type 1 Tat Protein J. Virol., December 1, 2004; 78(23): 13190 - 13196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Campbell, E. Pasquier, J. Watkins, V. Bourgarel-Rey, V. Peyrot, D. Esquieu, P. Barbier, J. de Mareuil, D. Braguer, P. Kaleebu, et al. The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis J. Biol. Chem., November 12, 2004; 279(46): 48197 - 48204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Moreau, G. Belliard, C. D. Partidos, F. Pradezinsky, H. Le Buanec, S. Muller, and C. Desgranges Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides J. Gen. Virol., October 1, 2004; 85(10): 2893 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Calzado, R. Sancho, and E. Munoz Human Immunodeficiency Virus Type 1 Tat Increases the Expression of Cleavage and Polyadenylation Specificity Factor 73-Kilodalton Subunit Modulating Cellular and Viral Expression J. Virol., July 1, 2004; 78(13): 6846 - 6854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Moreau, J. Hoebeke, D. Zagury, S. Muller, and C. Desgranges Generation and Characterization of Neutralizing Human Monoclonal Antibodies against Human Immunodeficiency Virus Type 1 Tat Antigen J. Virol., April 1, 2004; 78(7): 3792 - 3796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yao, O. Salvucci, A. R. Cardones, S. T. Hwang, Y. Aoki, M. De La Luz Sierra, A. Sajewicz, S. Pittaluga, R. Yarchoan, and G. Tosato Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis Blood, December 1, 2003; 102(12): 3900 - 3905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, I. Tikhonov, T. J. Ruckwardt, M. Djavani, J. C. Zapata, C. D. Pauza, and M. S. Salvato Monocytes Treated with Human Immunodeficiency Virus Tat Kill Uninfected CD4+ Cells by a Tumor Necrosis Factor-Related Apoptosis-Induced Ligand-Mediated Mechanism J. Virol., June 15, 2003; 77(12): 6700 - 6708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tikhonov, T. J. Ruckwardt, G. S. Hatfield, and C. D. Pauza Tat-Neutralizing Antibodies in Vaccinated Macaques J. Virol., March 1, 2003; 77(5): 3157 - 3166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Opi, J.-M. Peloponese Jr., D. Esquieu, G. Campbell, J. de Mareuil, A. Walburger, M. Solomiac, C. Gregoire, E. Bouveret, D. L. Yirrell, et al. Tat HIV-1 Primary and Tertiary Structures Critical to Immune Response Against Non-homologous Variants J. Biol. Chem., September 20, 2002; 277(39): 35915 - 35919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Estes, B. F. Keele, K. Tenner-Racz, P. Racz, M. A. Redd, T. C. Thacker, Y. Jiang, M. J. Lloyd, S. Gartner, and G. F. Burton Follicular Dendritic Cell-Mediated Up-Regulation of CXCR4 Expression on CD4 T Cells and HIV Pathogenesis J. Immunol., September 1, 2002; 169(5): 2313 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Agwale, M. T. Shata, M. S. Reitz Jr., V. S. Kalyanaraman, R. C. Gallo, M. Popovic, and D. M. Hone A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice PNAS, July 23, 2002; 99(15): 10037 - 10041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bres, R. Kiernan, S. Emiliani, and M. Benkirane Tat Acetyl-acceptor Lysines Are Important for Human Immunodeficiency Virus Type-1 Replication J. Biol. Chem., June 14, 2002; 277(25): 22215 - 22221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fanales-Belasio, S. Moretti, F. Nappi, G. Barillari, F. Micheletti, A. Cafaro, and B. Ensoli Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses J. Immunol., January 1, 2002; 168(1): 197 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Chensue Molecular Machinations: Chemokine Signals in Host-Pathogen Interactions Clin. Microbiol. Rev., October 1, 2001; 14(4): 821 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Caldwell, B. S. Egan, and V. L. Shepherd HIV-1 Tat Represses Transcription from the Mannose Receptor Promoter J. Immunol., December 15, 2000; 165(12): 7035 - 7041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. de Paulis, R. De Palma, L. Di Gioia, M. Carfora, N. Prevete, G. Tosi, R. S. Accolla, and G. Marone Tat Protein Is an HIV-1-Encoded {beta}-Chemokine Homolog That Promotes Migration and Up-Regulates CCR3 Expression on Human Fc{epsilon}RI+ Cells J. Immunol., December 15, 2000; 165(12): 7171 - 7179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Secchiero, D. Zella, S. Curreli, P. Mirandola, S. Capitani, R. C. Gallo, and G. Zauli Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication PNAS, December 8, 2000; (2000) 11512398. [Abstract] [Full Text]
|
|
|
|
|
|
H. Xiao, C. Neuveut, H. L. Tiffany, M. Benkirane, E. A. Rich, P. M. Murphy, and K.-T. Jeang Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1 PNAS, October 10, 2000; 97(21): 11466 - 11471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Secchiero, D. Zella, S. Curreli, P. Mirandola, S. Capitani, R. C. Gallo, and G. Zauli Engagement of CD28 Modulates CXC Chemokine Receptor 4 Surface Expression in Both Resting and CD3-Stimulated CD4+ T Cells J. Immunol., April 15, 2000; 164(8): 4018 - 4024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. McManus, K. Weidenheim, S. E. Woodman, J. Nunez, J. Hesselgesser, A. Nath, and J. W. Berman Chemokine and Chemokine-Receptor Expression in Human Glial Elements : Induction by the HIV Protein, Tat, and Chemokine Autoregulation Am. J. Pathol., April 1, 2000; 156(4): 1441 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zella, F. Romerio, S. Curreli, P. Secchiero, C. Cicala, D. Zagury, and R. C. Gallo IFN-{alpha}2b Reduces IL-2 Production and IL-2 Receptor Function in Primary CD4+ T Cells J. Immunol., March 1, 2000; 164(5): 2296 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Orsini, J.-L. Parent, S. J. Mundell, and J. L. Benovic Trafficking of the HIV Coreceptor CXCR4. ROLE OF ARRESTINS AND IDENTIFICATION OF RESIDUES IN THE C-TERMINAL TAIL THAT MEDIATE RECEPTOR INTERNALIZATION J. Biol. Chem., October 22, 1999; 274(43): 31076 - 31086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Gallo Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine PNAS, July 20, 1999; 96(15): 8324 - 8326. [Full Text] [PDF]
|
|
|
|
|
|
P. Secchiero, D. Zella, S. Curreli, P. Mirandola, S. Capitani, R. C. Gallo, and G. Zauli Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication PNAS, December 19, 2000; 97(26): 14620 - 14625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Pauza, P. Trivedi, M. Wallace, T. J. Ruckwardt, H. Le Buanec, W. Lu, B. Bizzini, A. Burny, D. Zagury, and R. C. Gallo Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques PNAS, March 28, 2000; 97(7): 3515 - 3519. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
